Bibliotecas PUC-SP - Busca Integrada

Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease.

par Alfred N Fonteh, Matthew Cipolla, Jiarong Chiang, Xianghong Arakaki, Michael G Harrington
Publié dans PLoS ONE (2014-01-01)

Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease.

par Alfred N Fonteh, Cora Ormseth, Jiarong Chiang, Matthew Cipolla, Xianghong Arakaki, Michael G Harrington
Publié dans PLoS ONE (2015-01-01)

Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimer's disease[S]

par Alfred N. Fonteh, Jiarong Chiang, Matthew Cipolla, Jack Hale, Fatimatou Diallo, Alejandra Chirino, Xianghong Arakaki, Michael G. Harrington
Publié dans Journal of Lipid Research (2013-10-01)

ABCA1‐Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease

par Hussein N. Yassine, Qingru Feng, Jiarong Chiang, Larissa M. Petrosspour, Alfred N. Fonteh, Helena C. Chui, Michael G. Harrington
Publié dans Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2016-02-01)

Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study.

par Michael G Harrington, Jiarong Chiang, Janice M Pogoda, Megan Gomez, Kris Thomas, Sarah Deboard Marion, Karen J Miller, Prabha Siddarth, Xinyao Yi, Feimeng Zhou, Sherri Lee, Xianghong Arakaki, Robert P Cowan, Thao Tran, Cherise Charleswell, Brian D Ross, Alfred N Fonteh
Publié dans PLoS ONE (2013-01-01)